Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;63(8):905-15.
doi: 10.1097/JIM.0000000000000239.

Cardiac Troponin Measurement in the Critically Ill: Potential for Guiding Clinical Management

Stacy Poe  1 , Robin H Vandivier-Pletsch, Michael Clay, Hector R Wong, Erin Haynes, Florence G Rothenberg
Affiliations

Cardiac Troponin Measurement in the Critically Ill: Potential for Guiding Clinical Management

Stacy Poe et al. J Investig Med. 2015 Dec.

Abstract

Background: Elevated cardiac troponin (cTn) in the absence of acute coronary syndromes (ACS) is associated with increased mortality in critically ill patients. There are no evidence-based interventions that reduce mortality in this group.

Objectives: We performed a retrospective investigation of the Veterans Administration Inpatient Evaluation Center database to determine whether drugs used in ACS (β-blockers, aspirin, and statins) are associated with reduced mortality in critically ill patients.

Methods: Thirty-day mortality was determined for non-ACS patients admitted to any Veterans Administration Intensive Care Unit between October 1, 2007, and September 30, 2008, adjusted for severity of illness. Troponin assay values were normalized across institutions.

Results: Multivariate analyses for 30-day mortality showed an odds ratio (OR) of 1.82 for patients with high cTn (P < 0.0001, cTn > 10% coefficient of variation) and 1.18 for intermediate cTn (P = 0.0021, cTn between lowest limit detectable and 10% coefficient of variation) compared with patients with no elevation, adjusting for severity of illness (n = 19,979). Logistic regression models showed that patients with no or intermediate elevations of cTn taking statins within 24 hours of cTn measurement had a lower mortality than patients not taking statins (OR, 0.66; 95% confidence interval [95% CI], 0.53-0.82; P = 0.0003), whereas patients with high cTn had a lower mortality if they were taking β-blockers or aspirin within 24 hours of cTn measurement compared to patients not taking β-blockers or aspirin (β-blockers: OR, 0.80; 95% CI, 0.68-0.94; P = 0.0077; aspirin: OR, 0.81;95% CI, 0.69-0.96; P = 0.0134).

Conclusions: This retrospective study confirms an association between elevated troponin and outcomes in critically ill patients without ACS and identifies statins, β-blockers, and aspirin as potential outcome modifiers in a cTn-dependent manner.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Branching algorithm describing VA-IPEC ICU patient population October 2007 to September 2008.
FIGURE 2
FIGURE 2
Distribution of primary diagnoses admitted to VA ICUs October 2007 to September 2008 (n = 19,979).
FIGURE 3
FIGURE 3
Relationship between 30-day mortality and troponin level: no cTn elevation, 10.7% 30-day mortality; intermediate cTn, 16.6% 30-day mortality; high cTn, 31.7% 30-day mortality.
FIGURE 4
FIGURE 4
Measurement of cTn in critically ill patients may help guide potentially life-saving therapy.
See this image and copyright information in PMC

References

    1. Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol. 2003; 41: 2004– 2009. - PubMed
    1. John J, Woodward DB, Wang Y, et al. Troponin-I as a prognosticator of mortality in severe sepsis patients. J Crit Care. 2010; 25: 270– 275. - PubMed
    1. Reynolds T, Cecconi M, Collinson P, et al. Raised serum cardiac troponin I concentrations predict hospital mortality in intensive care unit patients. Br J Anaesth. 2012; 109: 219– 224. - PubMed
    1. Stein R, Gupta B, Agarwal S, et al. Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome. Am J Cardiol. 2008; 102: 509– 512. - PubMed
    1. Vasile VC, Chai HS, Abdeldayem D, et al. Elevated cardiac troponin T levels in critically ill patients with sepsis. Am J Med. 2013; 126: 1114– 1121. - PubMed

Publication types